These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 9730562

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. The pathogenesis of hypertension in autosomal dominant polycystic kidney disease.
    Wang D, Strandgaard S.
    J Hypertens; 1997 Sep; 15(9):925-33. PubMed ID: 9321739
    [Abstract] [Full Text] [Related]

  • 46. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
    Park HC, Kang AY, Jang JY, Kim H, Han M, Oh KH, Kim SH, Noh JW, Cheong HI, Hwang YH, Ahn C.
    BMC Nephrol; 2015 Jun 20; 16():86. PubMed ID: 26092580
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R, Poliak R, Stiasny B, Schmieder RE, Schulze BD.
    Nephrol Dial Transplant; 2008 Feb 20; 23(2):573-9. PubMed ID: 17984104
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner.
    Pietrzak-Nowacka M, Safranow K, Czechowska M, Dutkiewicz G, Kornacewicz-Jach Z, Ciechanowski K.
    Kidney Blood Press Res; 2012 Feb 20; 36(1):301-9. PubMed ID: 23235185
    [Abstract] [Full Text] [Related]

  • 58. Ambulatory pulse pressure and its contributors in autosomal dominant polycystic kidney disease.
    Koska-Ścigała A, Jankowska M, Szyndler A, Narkiewicz K, Dębska-Ślizień A.
    Adv Clin Exp Med; 2022 May 20; 31(5):575-578. PubMed ID: 35543199
    [Abstract] [Full Text] [Related]

  • 59. Hypertension and renal injury in experimental polycystic kidney disease.
    Kennefick TM, Al-Nimri MA, Oyama TT, Thompson MM, Kelly FJ, Chapman JG, Anderson S.
    Kidney Int; 1999 Dec 20; 56(6):2181-90. PubMed ID: 10594794
    [Abstract] [Full Text] [Related]

  • 60. [The value of noninvasive 24-hour blood pressure measurement in patients with renoparenchymal, renovascular or severe essential hypertension].
    Hollenbeck M, Kutkuhn B, Bosma A, Morgera S, Grabensee B.
    Z Kardiol; 1992 Dec 20; 81 Suppl 2():29-32. PubMed ID: 1514308
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.